No fewer than 6,000 jobs are expected to be lost as five notable companies shut their production factories in Nigeria.

The PUNCH had reported that American multinational consumer goods company, Procter & Gamble, announced plans to terminate its on-ground operations in Nigeria, transforming the country into an import-focused market.

The manufacturing giant, headquartered in Cincinnati, Ohio, United States of America, joins a growing list of multinationals to dump Nigeria in 2023 owing to reasons that have revolved around business profitability.

Other multinational firms that have also left Nigeria in 2023 include Unilever Nig (home care and skin cleansing division), GlaxoSmithKline, Sanofi and Bolt Foods.



Ibadan Family Where Dad, Mum, Two Children Are Vulcanisers | Punch
The companies, in separate statements, alluded the painful decision to leave Nigeria to their plan to pursue an import-based model that would ensure business sustainability.

Preliminary checks by The PUNCH indicate that the departure of the five companies means approximately 6,000 direct and indirect jobs may have been lost.

P&G, the biggest of all five names, leaves Nigeria with a portfolio valued at $85bn with Nigeria contributing $50mn net sales. The company’s exit also means that approximately 5,000 jobs have been taken away from the economy.


GSK, on the other hand, left Nigeria with a market cap of N22bn. Even though the company had over 400 highly technical workers like pharmacists, microbiologists, biochemists, chemists, dentists, doctors etc, and more than 1000 other staff, it said around 160 employees would bear the brunt of this shift in business strategy in Nigeria.

Unilever Nigeria, on its part, leaves Nigeria with a home care and skin cleansing division worth N50bn. A total of 755 people worked for the company as of 2021.

In June, while speaking exclusively with The PUNCH, the President of the Manufacturers Association of Nigeria, Francis Meshioye, had said that some international manufacturing firms were planning to exit Nigeria as a result of the power crisis, coupled with the unpredictability of the country’s foreign exchange rate before it was recently unified.

Meshioye said, “The downsising of businesses in Nigeria, for instance, shows that businesses are not doing very well. So this power issue and other things have made some manufacturers, particularly international businessmen relocate from Nigeria to other countries.

“Therefore anything to reduce this energy cost will be very beneficial both to manufacturers and the masses in general. So it (power) is a high cost to us and a major driver in terms of cost. At the same time, it could lead to other things.”

Profits shrink

While many of the big firms that left Nigeria in 2023 have attributed their decision to business strategy, an analysis of the companies’ financials indicates shrinking profits while others have posted significant losses in recent memory.

For example, when Unilever Nigeria announced its exit from the home care and skin cleansing markets in Nigeria, the company said it did so “to find a more sustainable and profitable business model.”

However, a deep dive into the company’s financials showed a N1.09bn profit after tax loss in the third quarter of 2023.

Also, the company’s nine-month interim report showed a N389.30m profit before tax; however, a corporate income tax obligation of N1.48bn dragged the company’s bottom-line performance into negative territory.

Similarly, GSK, before announcing its exit saw its half-year revenue decrease to N7.75bn from N14.8bn.

Also, Sanofi, a French pharmaceutical multinational, which announced its exit from Nigeria last month, said “This strategic move is driven by our commitment to continually improve access to our medicines and to better serve our patients and the Nigerian health system.”

However, the company’s financials indicate that it had struggled to keep up profitability in Nigeria.

According to Ventures Africa, in 2019, May & Baker Nigeria announced a contract manufacturing agreement to produce four brands from Sanofi. This deal was an effort to boost local production.


It enabled May & Baker to use Sanofi’s facilities to manufacture flagyl tablets, suspensions, anti-infective medicines and anti-malaria drugs. By then, May & Baker’s revenue slowed by 9.57 per cent to N5.9 billion in the first nine months of 2019. Gross profits also fell by 9.36 per cent due to a sharp decline in sales.

At the top of the list of factors that have influenced the exit of international firms from Nigeria is the acute scarcity of foreign exchange. While announcing the decision to leave Nigeria, the Chief Financial Officer of P&G, Andre Schulten, said it was difficult to do business in Nigeria as a dollar-denominated organisation and the macroeconomic reality in Nigeria is responsible for its latest strategic decision.

https://punchng.com/over-6000-jobs-lost-to-foreign-firms-exit-man-fumes/